Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Vytorin Update: Big Pharma Strikes Back
- The saga over Vytorin, the expensive cholesterol pill that may be no better than older, cheaper "statin" drugs, has come to a familiar pass: The manufacturer backlash. Merck and Schering-Plough, the makers of Vytorin, saw their stocks crushed the day after cardiologists trashed the multi-billion-dollar drug at...
- Blog posts 2008-04-03
- IMS Health Reports 2004 Global Pharmaceutical Sales Grew 7 Percent to $550 Billion; China and Biotechnology Emerge as Key Growth Drivers
- FAIRFIELD, Conn. -- IMS Health (NYSE: RX), the world's leading provider of information and consulting solutions to the pharmaceutical and healthcare industries, today announced that audited and estimated unaudited global pharmaceutical sales grew 7 percent constant dollar in 2004 to US $550 billion. Nearly 45 percent, or $248 billion of...
- Research articles 2005-03-09
- BioDelivery Sciences Hires Proven Pharmaceutical Executive To Head Sales and Marketing Effort; Appointment of Former Altana Pharma AG and GlaxoSmithKline Executive Reflects BDSI's Commitment to Product Commercialization
- MORRISVILLE, N.C. -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced the appointment of Mark W. Salyer, a former executive with Altana Pharma AG and GlaxoSmithKline, to the newly created position of Executive Vice-President of Sales and Marketing. Mr. Salyer brings over 20 years of pharmaceutical experience to BDSI.
- Research articles 2006-01-09
- Dendrite Gives Shanghai SINE Medicine Company the Ability to Meet the Unique Needs of Chinese Pharmaceutical Market; Increased Penetration in Chinese Market Illustrates Growing Global Embrace of Dendrite Solutions
- BEDMINSTER, N.J. -- Dendrite International, Inc. (NASDAQ: DRTE), a leading provider of pharmaceutical industry solutions, today announced a comprehensive three-year agreement to provide SINE Pharmaceutical Company Co., Ltd, a subsidiary of Shanghai Pharmaceutical Group Co., Ltd SPGC and pioneer in China's growing pharmaceutical market, with components of Dendrite's Sales Solutions....
- Research articles 2006-06-02
- Key pharmaceutical markets except growth through 2005.(IMS Health Inc. forecasts growth in Latin America pharmaceutical markets)(Brief Article)(Industry Overview)(Statistical Data Included)
- Sales in seven key Latin American pharmaceutical markets will grow at a compound average rate of 7.8 percent constant dollar for the five years through 2005, according to a new study released by IMS Health of Westport. Strong pharmaceutical sales Sales in...
- Research articles 2001-04-16
- Venezuela: Aventis Pharma predicts US$70mil sales.
- Aventis Pharma, the company created from the merge of Hoechst and Rhone Poulenc, plans to win over the next 12 months a 6% share in the Venezuelan drugs & pharmaceuticals market where it currently has 5,6% and sales of US$70mil. Chairman Mr. ...
- Research articles 2000-01-25
- Brazil's Pharma Agency To Adopt FDA Standards.
- To REDUCE the production of counterfeit pharmaceuticals, the Brazilian sanitary controls agency within the ministry of health is moving toward the adoption of US Food and Drug Administration market control standards, says Sylvio di Girolamo, execut To REDUCE the production of counterfeit pharmaceuticals, the...
- Research articles 1999-03-15
- AstraZeneca Norway Standardizes on Siebel Pharma to Maximize Sales and Marketing Effectiveness; Leading Pharmaceutical Company Further Aligns Marketing and Sales Business Processes to Strengthen Relationships with Health Care Customers
- BARCELONA, Spain -- Siebel Systems, Inc. (Nasdaq:SEBL), the leading provider of customer-facing solutions, today announced that AstraZeneca Norway, a subsidiary of the leading pharmaceutical company, has selected Siebel Pharma to spearhead its program to maximize marketing and sales efficiency and effectiveness. The company will deploy Siebel's industry-specific CRM solution, including...
- Research articles 2005-04-18
- Active Pharmaceuticals ingredient watch. (Markets: Life Sciences).(Abbott Laboratories reports 2001 sales of $16.3 bn)(Brief Article)(Statistical Data Included)
- ABBOTT Laboratories reported 2001 sales of $16.3 billion, up 18.5 percent year over year, which includes US pharmaceuticals sales of $3.76 billion and international pharmaceuticals sales of $2.52 billion. ABBOTT Laboratories reported 2001 sales of $16.3 billion, up 18.5 percent year over...
- Research articles 2002-01-21
- Bayer changes tune on fate of pharma unit. (News).(Bayer AG drops insistance on majority control of pharmaceutical partnership)
- BAYER AG has lifted a major barrier to the merger of its pharmaceutical unit with another drugmaker by dropping its insistence on majority control of a pharmaceutical partnership. "A possible partnership must not be prevented by rigid in ...
- Research articles 2002-11-18
- Johnson & Johnson reports strong second quarter pharmaceutical sales. (News).(Brief Article)
- JOHNSON & Johnson (J&J) posted solid second quarter results, with underlying earnings up 15 percent to $2.1 billion based on a 14 percent increase in sales to $10.3 billion. Worldwide pharmaceutical sales accounted for $4.9 billion of that JOHNSON & Johnson (J&J) posted...
- Research articles 2003-07-21
- Nutri Pharmaceuticals Research, Inc. Statement of Operations for First Quarter 2007 Reflects Profitable Net from Almost a Half Million in Sales
- LAS VEGAS -- Nutri Pharmaceuticals Research, Inc. (Pink Sheets: NRPR) is pleased to report that its First Quarter 2007 Statement of Operations indicates a profit from gross revenue of approximately $500,000 in sales, an increase from 2006 of over $60,000. Nutri Pharmaceuticals Research credits their continued success to their innovative...
- Research articles 2007-05-03
- Dendrite Announces Schering-Plough to Enhance Sales Force Effectiveness and Business Planning Solution With Dendrite's Proven .NET Framework; New Solution to be Deployed to U.S. Pharmaceutical Field Force Users
- BEDMINSTER, N.J. -- Dendrite International, Inc. (NASDAQ:DRTE), a leading provider of pharmaceutical industry solutions, today announced that Schering Corporation, a subsidiary of Schering-Plough Corporation, has signed a five-year agreement to enhance VISION, its proprietary sales force effectiveness SFE and business planning solution, for its U.S.-based pharmaceutical field sales organization. As...
- Research articles 2006-06-30
- Dendrite Signs Comprehensive Software Services Agreement with Esprit Pharma; Esprit Looks to Dendrite's WebForce™ Express and Full Suite of Sales Support Services to Help Foster Growth and Market Expansion
- BEDMINSTER, N.J. -- Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of sales, marketing, clinical and compliance solutions for the life science and pharmaceutical industries, today announced that Esprit Pharma, Inc. has signed a comprehensive, three-year several million dollar software and services agreement with Dendrite. This customer win was previously...
- Research articles 2005-08-23
- Pharma's Consolidation Creates New Kind of Player.(Statistical Data Included)
- Companies become broader and more efficient. THE RECENT merger and acquisition activity in the drug industry is changing the landscape of pharmaceutical players. Within just the past two years, consolidation has created a new breed of super dr Companies...
- Research articles 2000-05-29
- JOHNSON & JOHNSON.(net earnings on sales )(Brief Article)(Statistical Data Included)
- JOHNSON & JOHNSON reported $1.5 billion in net earnings on sales of $8.3 billion for the second quarter of 2001, up 8.7 and 8.8 percent, respectively, over the prior year's quarter. Global pharma sales were up 14.2 percent to total $3.9 ... JOHNSON &...
- Research articles 2001-07-23
- Aventis Draws Praise From Analysts.
- Hoechst and Rhone-Poulenc both bring best-selling drugs to the joint venture. ANALYSTS ARE PRAISING Aventis, the new life sciences company created by Hoechst AG and Rhone-Poulenc SA. They cite the company's hefty research and development budg Hoechst and...
- Research articles 1998-12-14
- Fujitsu Personal Systems' Stylistic 500 Streamlines Searle Pharmaceuticals' Sales Force Operations
- SANTA CLARA, Calif.--BUSINESS WIRE--Jan. 15, 1996--Fujitsu Personal Systems is helping Searle pharmaceuticals, a $1.5 billion subsidiary of Monsanto Company, solve a complex problem: How does one of the nation's leading pharmaceutical companies improve its sales force's ability to maintain accurate and timely sales and inventory reports, while at the same...
- Research articles 1996-01-15
- The management behind the molecules: pharmaceutical CEOs outline their key revenue drivers. (Focus 2003: Active Pharmaceutical Ingredients).
- Many concede that 2003 will be a transition year for the major pharmaceutical companies in terms of new drug development and product launches. That will put an even greater pressure on companies' mainstay products as pharmaceutical executives work Many concede that 2003 will...
- Research articles 2003-03-17
- Wyeth posts 13 percent profit gain; Bristol-Myers' net falls 30 percent. (News).(Brief Article)
- PHARMACEUTICAL company earnings are coming in mixed with Wyeth, the former American Home Products, generating profit growth and the beleaguered Bristol-Myers Squibb Company posting a significant decline in earnings. Wyeth posted a 13 percent PHARMACEUTICAL company earnings...
- Research articles 2002-04-29
- << Previous
- page 1 of 5
- Next >>
Content Types
Refining Tags
- Sales Strategy (38 results)
- Sales Force Management (28 results)
- Marketing (15 results)
- Pfizer Inc. (14 results)
- company (12 results)
- Merck & Co. Inc. (10 results)
- Sales Force (7 results)
- John Maas (7 results)
- Job (6 results)
- Earnings (6 results)
- Business Operations (6 results)
- R&D (6 results)
- health care (5 results)
- Human Resources (5 results)
- Marketing Research (5 results)
- Jim Edwards (5 results)
- life science (4 results)
- Finance (4 results)
- Wyeth (4 results)
- Research & Development (4 results)
- Strategy (4 results)
- Aventis (4 results)
- Workforce Management (4 results)
- Bayer AG (4 results)
- Software (4 results)
- FDA (4 results)
- David P. Hamilton (3 results)
- revenue (3 results)
- Financial (3 results)
- Biotechnology (3 results)
- Johnson & Johnson (3 results)
- Management (3 results)
- Seeking Alpha (3 results)
- Abbott Laboratories Inc. (3 results)
- Enterprise Software (3 results)
- Lilly (3 results)
- Siebel Systems Inc. (3 results)
- Roche Holding AG (3 results)
